Meeting
2023 ASCO Annual Meeting
Transforming growth factor-b1 and soluble co-inhibitory immune checkpoints as putative drivers of immune suppression in advanced basal cell carcinoma.
Authors
Bernardo Leon Rapoport
Department of Immunology, Faculty of Health Science, University of Pretoria, Pretoria, South Africa
Bernardo Leon Rapoport , Ronald Anderson , Nonkululeko Malinga , Helen C. Steel , Pieter Meyer , Teresa Smit , Mahlatse Kgokolo
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Melanoma/Skin Cancers
Track
Melanoma/Skin Cancers
Sub Track
Biologic Correlates
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 9567)
DOI
10.1200/JCO.2023.41.16_suppl.9567
Abstract #
9567
Poster Bd #
330
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Dysregulation of soluble immune checkpoint proteins in newly-diagnosed early breast cancer patients.
First Author: Bernardo Leon Rapoport
Poster
2018 ASCO Annual Meeting
Treg infiltration and the expression of immune checkpoints associated with T cell exhaustion in AML.
First Author: Patrick Williams
Poster
2018 ASCO-SITC Clinical Immuno-Oncology Symposium
Prognostic value of the expression of immunomodulatory targets in surgically resected lung adenocarcinoma.
First Author: Kazuya Takamochi
Poster
2023 ASCO Annual Meeting
Exploring the potential of combination immune checkpoint strategies in non-small cell lung cancer (NSCLC).
First Author: Aakash Desai